MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate)
Immunogen: Human MAGE-A1 full length recombinant protein
Isotype: IgG1, kappa
Species Reactivity: Human, Rat and Dog. Others not known.
Positive Control: Melanoma cell lines. Melanomas, gliomas, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, and renal cell carcinomas.
Specificity: Recognizes a protein of 42-46kDa, identified as MAGE-1. This antibody does not cross-react with MAGE-2, -3, -4, -6 -9, -10, -or -12 proteins.